Patents by Inventor Roser Pallisse Bergwerf

Roser Pallisse Bergwerf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10100080
    Abstract: The present invention relates generally to robust split inteins. The split inteins described herein are active over a large temperature range, including temperatures as low as 0° C., over a wide pH range, and in the presence of chaotropic salts. The split inteins also show high tolerance to sequence variability in fused heterologous polypeptides and therefore are useful in protein purification and engineering techniques.
    Type: Grant
    Filed: September 28, 2012
    Date of Patent: October 16, 2018
    Assignee: ERA BIOTECH, S.A.
    Inventors: Roser Pallisse Bergwerf, Stefan Robert Schmidt, Didac Marco Feliu, Patricia Karina Carvajal Vallejos
  • Publication number: 20150335720
    Abstract: A fusion protein that is expressed in a recombinant protein body-like assembly (RPBLA) in host eukaryotic cells and organisms is disclosed. More particularly, a biologically active polypeptide fused to a protein sequence that mediates the induction of RPBLA formation is expressed and accumulated in host cells after transformation with an appropriate vector. The eukaryotic host cell does not produce protein bodies in the absence of the fusion protein. Methods for preparing and using the RPBLAs and the fusion protein are also disclosed, as are nucleic acid molecules that encode the fusion proteins.
    Type: Application
    Filed: May 26, 2015
    Publication date: November 26, 2015
    Inventors: Peter Bernard HEIFETZ, Blanca LLOMPART ROYO, Pablo MARZÁBAL LUNA, Miriam BASTIDA VIRGILI, Maria Dolores LUDEVID MÚGICA, Margarita TORRENT QUETGLAS, Kevin James O'CONNER, Roser Pallisse BERGWERF, Maria Immaculada LLOP TOUS
  • Publication number: 20150232507
    Abstract: The present invention relates generally to robust split inteins. The split inteins described herein are active over a large temperature range, including temperatures as low as 0° C., over a wide pH range, and in the presence of chaotropic salts. The split inteins also show high tolerance to sequence variability in fused heterologous polypeptides and therefore are useful in protein purification and engineering techniques.
    Type: Application
    Filed: September 28, 2012
    Publication date: August 20, 2015
    Applicant: ERA BIOTECH, S.A.
    Inventors: Roser Pallisse Bergwerf, Stefan Robert Schmidt, Dídac Marco Feliu, Patricia Karina Carvajal Vallejos
  • Patent number: 8163880
    Abstract: A fusion protein that is expressed in a recombinant protein body-like assembly (RPBLA) in host eukaryotic cells and organisms is disclosed. More particularly, a biologically active polypeptide fused to a protein sequence that mediates the induction of RPBLA formation is expressed and accumulated in host cells after transformation with an appropriate vector. The eukaryotic host cell does not produce protein bodies in the absence of the fusion protein. Methods for preparing and using the RPBLAs and the fusion protein are also disclosed, as are nucleic acid molecules that encode the fusion proteins.
    Type: Grant
    Filed: February 22, 2007
    Date of Patent: April 24, 2012
    Assignee: ERA Biotech S.A.
    Inventors: Peter Bernard Heifetz, Blanca Llompart Royo, Pablo Marzábal Luna, Miriam Bastida Virgili, Ma Dolores Ludevid Múgica, Margarita Torrent Quetglas, Kevin James O'Connor, Roser Pallisse Bergwerf, Ma Immaculada Ilop Tous
  • Publication number: 20120020992
    Abstract: A fusion protein that is expressed in a recombinant protein body-like assembly (RPBLA) in host eukaryotic cells and organisms is disclosed. More particularly, a biologically active polypeptide fused to a protein sequence that mediates the induction of RPBLA formation is expressed and accumulated in host cells after transformation with an appropriate vector. The eukaryotic host cell does not produce protein bodies in the absence of the fusion protein. Methods for preparing and using the RPBLAs and the fusion protein are also disclosed, as are nucleic acid molecules that encode the fusion proteins.
    Type: Application
    Filed: June 22, 2011
    Publication date: January 26, 2012
    Applicant: ERA BIOTECH, S.A.
    Inventors: Peter Bernard HEIFETZ, Blanca LLOMPART ROYO, Pablo MARZÁBAL LUNA, Miriam BASTIDA VIRGILI, Mª Dolores LUDEVID MÚGICA, Margarita TORRENT QUETGLAS, Kevin James O'CONNER, Roser Pallisse BERGWERF, Mª Immaculada LLOP TOUS